Science Historical Income Statement

SIS Stock

28.50 1.00 3.39%

Historical analysis of Science In income statement accounts such as Total Revenue of 75.7 M, Gross Profit of 32.4 M, Other Operating Expenses of 87.4 M or Cost Of Revenue of 43.3 M can show how well Science in Sport performed in making a profits. Evaluating Science In income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Science In's future profits or losses.

Cash Flow Balance Sheet Income Statement

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Science in Sport latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Science in Sport is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science in Sport. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

About Science Income Statement Analysis

Science in Sport Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Science In shareholders. The income statement also shows Science investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Science In Income Statement Chart

At present, Science In's Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 19.7 M, whereas Operating Income is projected to grow to (8.3 M).

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Interest Income

Total Revenue

Total revenue comprises all receipts Science in Sport generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Science in Sport minus its cost of goods sold. It is profit before Science In operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Interest Income

Income earned from the investment of cash or from lending money to others, including interest from bank accounts, bonds, or other interest-bearing investments.

Most accounts from Science In's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Science in Sport current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Science in Sport. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

	2022	2023	2024	2025 (projected)
Gross Profit	26.9M	26.8M	30.9M	32.4M
Total Revenue	63.8M	62.7M	72.1M	75.7M

Gross Profit Total Revenue

Science In income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Research Development	Net Income From Continuing Ops	Tax Provision	Net Interest Income	Interest Income	Reconciled Depreciation
Depreciation And Amortization		0.83	0.99	0.72	0.96	0.93	0.97	-0.88	-0.86	-0.43	0.97	0.96	-0.89	-0.89	-0.89	0.19	0.61	-0.89	0.27	-0.91	0.04	1.0
Interest Expense	0.83		0.84	0.44	0.7	0.66	0.74	-0.83	-0.82	-0.61	0.72	0.74	-0.86	-0.93	-0.82	-0.06	0.44	-0.83	0.0	-0.9	-0.17	0.84
Selling General Administrative	0.99	0.84		0.7	0.94	0.91	0.95	-0.89	-0.87	-0.46	0.95	0.95	-0.9	-0.87	-0.89	0.19	0.63	-0.89	0.25	-0.92	0.04	0.99
Selling And Marketing Expenses	0.72	0.44	0.7		0.88	0.9	0.87	-0.76	-0.77	-0.47	0.85	0.88	-0.74	-0.56	-0.78	0.49	0.71	-0.77	0.59	-0.45	0.26	0.7
Total Revenue	0.96	0.7	0.94	0.88		0.99	1.0	-0.86	-0.85	-0.43	1.0	0.99	-0.86	-0.78	-0.88	0.35	0.68	-0.88	0.44	-0.76	0.17	0.95
Gross Profit	0.93	0.66	0.91	0.9	0.99		0.99	-0.84	-0.83	-0.41	0.98	0.99	-0.84	-0.73	-0.86	0.39	0.74	-0.85	0.48	-0.71	0.22	0.91
Other Operating Expenses	0.97	0.74	0.95	0.87	1.0	0.99		-0.89	-0.88	-0.47	1.0	1.0	-0.89	-0.81	-0.91	0.34	0.68	-0.9	0.43	-0.79	0.12	0.96
Operating Income	-0.88	-0.83	-0.89	-0.76	-0.86	-0.84	-0.89		1.0	0.78	-0.87	-0.9	1.0	0.89	0.99	-0.24	-0.58	0.99	-0.32	0.84	0.16	-0.87
Ebit	-0.86	-0.82	-0.87	-0.77	-0.85	-0.83	-0.88	1.0		0.81	-0.86	-0.89	0.99	0.88	0.99	-0.28	-0.57	0.98	-0.34	0.82	0.16	-0.85
Ebitda	-0.43	-0.61	-0.46	-0.47	-0.43	-0.41	-0.47	0.78	0.81		-0.43	-0.51	0.76	0.61	0.75	-0.22	-0.29	0.74	-0.22	0.46	0.43	-0.41
Cost Of Revenue	0.97	0.72	0.95	0.85	1.0	0.98	1.0	-0.87	-0.86	-0.43		0.99	-0.88	-0.81	-0.89	0.32	0.64	-0.89	0.41	-0.8	0.13	0.96
Total Operating Expenses	0.96	0.74	0.95	0.88	0.99	0.99	1.0	-0.9	-0.89	-0.51	0.99		-0.9	-0.8	-0.91	0.35	0.72	-0.91	0.44	-0.78	0.12	0.94
Income Before Tax	-0.89	-0.86	-0.9	-0.74	-0.86	-0.84	-0.89	1.0	0.99	0.76	-0.88	-0.9		0.92	0.99	-0.22	-0.57	0.99	-0.3	0.87	0.17	-0.88
Total Other Income Expense Net	-0.89	-0.93	-0.87	-0.56	-0.78	-0.73	-0.81	0.89	0.88	0.61	-0.81	-0.8	0.92		0.89	-0.04	-0.42	0.9	-0.11	0.93	0.22	-0.89
Net Income	-0.89	-0.82	-0.89	-0.78	-0.88	-0.86	-0.91	0.99	0.99	0.75	-0.89	-0.91	0.99	0.89		-0.31	-0.6	1.0	-0.4	0.84	0.19	-0.88
Income Tax Expense	0.19	-0.06	0.19	0.49	0.35	0.39	0.34	-0.24	-0.28	-0.22	0.32	0.35	-0.22	-0.04	-0.31		0.46	-0.31	0.94	-0.01	-0.26	0.19
Research Development	0.61	0.44	0.63	0.71	0.68	0.74	0.68	-0.58	-0.57	-0.29	0.64	0.72	-0.57	-0.42	-0.6	0.46		-0.58	0.54	-0.45	0.16	0.6
Net Income From Continuing Ops	-0.89	-0.83	-0.89	-0.77	-0.88	-0.85	-0.9	0.99	0.98	0.74	-0.89	-0.91	0.99	0.9	1.0	-0.31	-0.58		-0.4	0.85	0.21	-0.88
Tax Provision	0.27	0.0	0.25	0.59	0.44	0.48	0.43	-0.32	-0.34	-0.22	0.41	0.44	-0.3	-0.11	-0.4	0.94	0.54	-0.4		-0.06	-0.23	0.27
Net Interest Income	-0.91	-0.9	-0.92	-0.45	-0.76	-0.71	-0.79	0.84	0.82	0.46	-0.8	-0.78	0.87	0.93	0.84	-0.01	-0.45	0.85	-0.06		0.2	-0.92
Interest Income	0.04	-0.17	0.04	0.26	0.17	0.22	0.12	0.16	0.16	0.43	0.13	0.12	0.17	0.22	0.19	-0.26	0.16	0.21	-0.23	0.2		0.03
Reconciled Depreciation	1.0	0.84	0.99	0.7	0.95	0.91	0.96	-0.87	-0.85	-0.41	0.96	0.94	-0.88	-0.89	-0.88	0.19	0.6	-0.88	0.27	-0.92	0.03

Click cells to compare fundamentals

Science In Account Relationship Matchups

Science In income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	3.2M	3.6M	4.8M	6.3M	7.2M	7.5M
Interest Expense	79K	119K	757K	1.6M	1.8M	1.9M
Selling General Administrative	9.1M	10.4M	14.1M	16.3M	18.8M	19.7M
Selling And Marketing Expenses	14.4M	19.6M	17.6M	14.0M	16.1M	10.2M
Total Revenue	50.4M	62.5M	63.8M	62.7M	72.1M	75.7M
Gross Profit	24.6M	31.4M	26.9M	26.8M	30.9M	32.4M
Other Operating Expenses	52.6M	67.8M	73.6M	72.4M	83.3M	87.4M
Operating Income	(2.2M)	(5.2M)	(9.8M)	(9.7M)	(8.8M)	(8.3M)
Ebit	(2.3M)	(5.5M)	(10.0M)	(9.7M)	(8.8M)	(8.3M)
Ebitda	846K	(1.8M)	(5.2M)	(3.5M)	(3.1M)	(3.3M)
Cost Of Revenue	25.8M	31.2M	36.8M	35.8M	41.2M	43.3M
Total Operating Expenses	26.8M	36.6M	36.8M	36.6M	42.0M	44.2M
Income Before Tax	(2.3M)	(5.3M)	(10.6M)	(11.3M)	(10.2M)	(9.7M)
Total Other Income Expense Net	(36K)	(114K)	(757K)	(1.6M)	(1.4M)	(1.3M)
Net Income	(1.7M)	(6.8M)	(10.9M)	(11.3M)	(10.2M)	(9.6M)
Income Tax Expense	(545K)	1.5M	332K	(12K)	(13.8K)	(13.1K)
Research Development	383K	693K	249K	464K	533.6K	362.8K
Net Income From Continuing Ops	(1.7M)	(6.8M)	(10.9M)	(11.3M)	(10.2M)	(9.6M)
Net Income Applicable To Common Shares	(5.6M)	(1.7M)	(6.8M)	(10.9M)	(9.8M)	(9.3M)
Tax Provision	(545K)	1.5M	332K	(12K)	(13.8K)	(13.1K)
Net Interest Income	(36K)	(114K)	(757K)	(1.6M)	(1.4M)	(1.3M)
Reconciled Depreciation	3.2M	3.6M	4.8M	6.3M	7.2M	7.5M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

CRM	Salesforce
C	Citigroup
GM	General Motors

Other Information on Investing in Science Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Science Historical Income Statement

About Science Income Statement Analysis

Science In Income Statement Chart

Total Revenue

Gross Profit

Interest Income

Science In income statement Correlations

Science In Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Science In income statement Accounts

Also Currently Popular

Other Information on Investing in Science Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Operating Income

Total Other Income Expense Net	- 0.93	Interest Expense
Reconciled Depreciation	- 0.92	Net Interest Income
Net Interest Income	- 0.92	Selling General Administrative
Net Income From Continuing Ops	- 0.91	Total Operating Expenses
Net Income	- 0.91	Total Operating Expenses
Net Income	- 0.91	Other Operating Expenses